CN Patent

CN104402862B — 艾立替尼的制备方法

Assigned to Juancheng Tairui Chemical Co ltd · Expires 2016-10-05 · 10y expired

What this patent protects

本发明揭示了一种艾立替尼(Alectinib，I)的制备方法，其制备步骤包括：6‑氰基‑1H‑吲哚‑3‑羧酸酯与4‑乙基‑3‑(4‑吗啉‑4‑基‑哌啶‑1‑基)‑α，α‑二甲基苯甲醇经缩合、水解和环合反应制得艾立替尼(I)。该制备方法原料易得，工艺简洁，经济环保，适合工业化生产。

USPTO Abstract

本发明揭示了一种艾立替尼(Alectinib，I)的制备方法，其制备步骤包括：6‑氰基‑1H‑吲哚‑3‑羧酸酯与4‑乙基‑3‑(4‑吗啉‑4‑基‑哌啶‑1‑基)‑α，α‑二甲基苯甲醇经缩合、水解和环合反应制得艾立替尼(I)。该制备方法原料易得，工艺简洁，经济环保，适合工业化生产。

Drugs covered by this patent

alectinib-hydrochloride (ALECTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN104402862B
Jurisdiction: CN
Classification: —
Expires: 2016-10-05
Drug substance claim: No
Drug product claim: No
Assignee: Juancheng Tairui Chemical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.